Overview
Shehu Abdullahi practices in Kano, Nigeria. Abdullahi is highly rated in 6 conditions, according to our data. Their top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
Their clinical research consists of co-authoring 28 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaAbdullahi isDistinguished. Learn about Anemia.
- Congenital Hemolytic AnemiaAbdullahi isDistinguished. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyAbdullahi isDistinguished. Learn about Hemoglobinopathy.
- Hemolytic AnemiaAbdullahi isDistinguished. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseAbdullahi isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- StrokeAbdullahi isAdvanced. Learn about Stroke.
- Experienced
- Bilirubin EncephalopathyAbdullahi isExperienced. Learn about Bilirubin Encephalopathy.
- Hemolytic Disease of the NewbornAbdullahi isExperienced. Learn about Hemolytic Disease of the Newborn.
- JaundiceAbdullahi isExperienced. Learn about Jaundice.
- MalnutritionAbdullahi isExperienced. Learn about Malnutrition.
- Oral CancerAbdullahi isExperienced. Learn about Oral Cancer.
- RetinoblastomaAbdullahi isExperienced. Learn about Retinoblastoma.